Introduction

Optical coherence tomography angiography (OCTA) has recently been spotlighted as a technology capable of noninvasively evaluating microvascularity across various retinal layers with good reproducibility [1,2,3]. Since the first report of decreased optic nerve head (ONH) perfusion in glaucoma using OCTA [4], multiple studies have demonstrated reduced peripapillary or ONH [1, 2, 5,6,7,8] and macular [9,10,11,12,13,14] perfusion in glaucoma patients via OCTA. Early OCTA studies focused on primary insult sites in glaucoma (e.g., ONH and peripapillary region). Recent macular vascular structure studies have also reported various findings. The reasons why these studies have focused on the macular vessel density (mVD) in glaucoma and impressive findings about mVD are as follows. First, glaucomatous optic neuropathy results in retinal ganglion cell (RGC) loss. The macula is among the most metabolically active eye tissues [15, 16] and includes half of all RGCs [17, 18], which depend on regional retinal capillary networks to meet their high metabolic requirements. Therefore, mVD can be an important factor affecting the viability of damaged RGCs in glaucoma. Second, there is an increasing body of evidence that mVD is a good reflection of functional loss and structural macular thinning [12, 13]. Third, serial OCTA measurements reveal glaucomatous change with mVD in eyes without evidence of altered ganglion cell complex thickness [11]. This suggests the possibility that changes of mVD may occur prior to structural changes in ganglion cell layer in glaucoma. Therefore, macular vascular indexing using OCTA may play a pivotal role in understanding and evaluating the glaucoma progression.

The purpose of the current study was to investigate factors, especially systemic blood pressure (BP), which may affect mVD in healthy and glaucomatous eyes. We also performed subgroup analyses of mVD categorized based on their history of disc haemorrhage (DH).

Materials and methods

Study design and subjects

This study adhered to the tenets of the Declaration of Helsinki, and Institutional Review Board approval was obtained at the Severance Hospital (4-2019-0371). Patients identified in the spectral domain optical coherence tomography (SD-OCT) database who had been treated from July 2017 to July 2018 in the glaucoma unit of Severance Hospital of Yonsei University were examined. This retrospective observational cross-sectional study included 92 eyes from 58 healthy subjects and 179 eyes from 103 patients with a definitive diagnosis of open-angle glaucoma (primary open-angle glaucoma, pigment dispersion glaucoma, pseudoexfoliative glaucoma, or preperimetric glaucoma).

Glaucoma was diagnosed based on a clinical examination demonstrating a defective optic nerve rim (notching or localized thinning), which is characteristic of glaucoma. Retinal nerve fibre layer (RNFL) thickness and OCT deviation maps (CirrusTM HD-OCT 5000; Zeiss, Dublin, CA) were reviewed in all patients. All glaucoma cases demonstrated focal RNFL thinning consistent with funduscopic disc findings. For perimetric glaucoma, Humphrey Swedish Interactive Threshold Algorithm 24-2 visual fields had at least one of the following three characteristics: (1) a glaucoma hemifield test outside normal limits, (2) pattern standard deviation outside normal limits (P < 0.05), or (3) a cluster of three or more adjacent points in locations characteristic of glaucoma, all of which were reduced on the pattern deviation plot at a P value of < 5%. Preperimetric glaucoma eyes had an optic nerve rim defect, consistent OCT findings, and no qualifying VF findings. If all of the above conditions were met and pseudoexfoliation and pigment dispersion were suspected on both slit-lamp and gonioscopic examinations, the appropriate diagnosis was made.

As a healthy subject, we included those who were diagnosed as not having glaucoma among those who wanted to be screened for glaucoma. Healthy subjects in the present study had normal clinical examination results, including non-glaucomatous optic discs and an intraocular pressure (IOP) of 21 mmHg or less. Inclusion criteria for both the glaucoma and healthy groups was an age of 18 years and older. Exclusion criteria included known spherical refractive error greater than +6.00 dioptres or less than −9.00 dioptres, macular or other retinal or optic nerve disease, history of ocular trauma or ocular surgery other than uncomplicated cataract and glaucoma surgery, and OCT signal strength of 6 or less (out of 10).

Demographic information collected from the patient medical records included age, sex, IOP, systolic and diastolic BP, diagnosis of diabetes or hypertension, history of DH, VF mean deviation (MD), and visual field index score. Within 4 h on the same day when OCT and OCTA were performed, all subjects underwent slit-lamp biomicroscopy, IOP measurement using Goldman applanation tonometry, and systemic BP measurement using an automated BP metre. Patients’ BP was taken while seated after waiting 20 min in a waiting room. The same automated BP monitor was used in the clinic to reduce variability owing to instrument differences or cuff size. The mean arterial pressure (MAP) was calculated as MAP = 1/3 systolic BP + 2/3 diastolic BP.

To confirm the presence of DH, only glaucoma patients who were managed for 3 years or more were included. If DH was confirmed in the corresponding eye within the previous 3 years of medical records, the subject was classified as being DH positive. Most of patients had VF test (Humphrey Field Analyzer II 24-2; Zeiss) on the same day as the OCTA test. If the test dates were different, the VF test performed on the date closest to the OCTA test was used for analyses.

OCT image acquisition

All subjects underwent OCT imaging of the ganglion cell-inner plexiform layer (GCIPL) thickness (CirrusTM HD-OCT 5000; Zeiss) and OCT angiography imaging (Zeiss AngioPlex® OCT Angiography powered by CirrusTM HD-OCT 5000). Macular Cube 6 × 6 mm scan protocol for GCIPL evaluation was acquired. Rather than 3 × 3 mm (about ±4.95° from the foveal centre) volumetric scans, 6 × 6 mm (about ± 9.9° from the foveal centre) ones were used [19] as the thickest portion of the RGC layer lies within ± 8° of the foveal centre [20, 21]. Mean GCIPL thickness is based on ganglion cell analysis of an area outlined by two ellipsoids. The outer ellipsoid has a vertical diameter of 4 mm and a horizontal diameter of 4.8 mm and the inner blacked out ellipsoid has a vertical diameter of 1 mm and a horizontal diameter of 1.2 mm around the fovea. The AngioPlex® OCTA technology used the optical microangiography-complex algorithm to analyse changes in the complex signal (both intensity and phase changes within sequential B-scans performed at the same position) [22, 23] and then generate en face microvascular images in a 6 × 6 mm region. Vascular images of the superficial and deep layers of the retina are displayed separately. Boundaries of the superficial and deep retinal layer slab were automatically determined. The inner surface of the superficial retinal layer (SRL) was defined by the internal limiting membrane (ILM). The outer surface of the SRL was an approximation of the inner plexiform layer (IPL), where the IPL was estimated to be 70% of the thickness between the ILM and retinal pigmented epithelium. The segmentation software automatically detected retinal layer boundaries from structural OCT cross-sectional images by measuring the OCT signal gradients and creating SRL en face images of the macular regions. The AngioPlex® OCTA technology includes software that automatically analyses mVD percentage data in the SRL and divides mVD scans into three areas: (1) a central circle mVD (≤1 mm), (2) an inner circle mVD (1–3 mm), and (3) an outer circle mVD (3–6 mm). Total mVD values for the whole scan area were used in subsequent analyses. The AngioPlex® incorporates FastTrac retinal-tracking technology to reduce motion artefacts. All scans were individually reviewed by one glaucoma specialist to assess image quality (i.e., signal strength, segmentation error, loss of fixation, motion artefact, and media opacity). Substandard scans were excluded.

Statistical analyses

Data were imported into SPSS 23.0 (SPSS Inc., Chicago, IL, USA) for further statistical analyses. Normal distribution of the data was checked using the Kolmogorov–Smirnov test and Q-Q plot. Data were expressed as mean ± standard deviation (SD) for Gaussian distributed values. Independent t tests were used to compare differences in continuous variables between the two groups. F test was performed prior to independent t test and indicated that the data had the equality of variance across the group. Exact chi-square tests were used to test differences between categorical variables. Correlations between mVD percentage data and demographic factors, systemic BP, and eye-specific parameters were evaluated using multiple linear regression analyses. Multivariate linear regression modelling was performed, adjusting significant variables with reference to the univariate linear regression results. P values < 0.05 were considered statistically significant.

Results

Of 557 eyes from 286 patients who underwent OCT and OCTA macula imaging, 179 eyes from 103 glaucoma patients and 92 healthy eyes from 58 control subjects met our inclusion and exclusion criteria after exclusion owing to poor image quality, as per the conditions described above. Table 1 summarizes the baseline characteristics of the study subjects. There were significant differences in the ages and prevalence of hypertension between the healthy and glaucomatous eyes.

Table 1 Participant characteristics.

Simple linear regression analysis was performed for the effect of each factor on mVD and multiple linear regression analysis of mVD was obtained based on age, MAP, MD and GCIPL thickness. This multivariate model was chosen on the basis of results of simple linear regression analysis in each controls, glaucoma group and subgroup of glaucoma. Any factors that appeared significance in simple linear regression were included for multivariate analysis.

In the healthy eyes, univariate analyses revealed that age, MD, and GCIPL thickness were significantly associated with mVD. (Table 2). The multivariate analyses revealed that age was the only factor that was significantly and inversely associated with mVD in healthy eyes (β = −0.033, P = 0.045).

Table 2 Association between vessel density and demographic and ocular variables in control eyes.

In glaucomatous eyes, age, MD, and GCIPL thickness were associated with mVD, similar to that observed in healthy eyes (Table 3). In the multivariate analyses, age retained an inverse association with mVD (β = −0.040, P = 0.018). In addition, MD was significantly associated with mVD (β = 0.107, P = 0.002). This association was stronger than that with age.

Table 3 Association between vessel density and demographic and ocular variables in total glaucomatous eyes.

We performed subgroup analyses depending on the history of DH in the corresponding eyes. There was no significant difference between the two subgroups except for IOP (Table 4). The average IOP was slightly lower in the glaucomatous eyes with DH than in those without DH (mean ± SD; 13.4 ± 4.12 vs. 15.1 ± 3.93, P = 0.010). In glaucomatous eyes without DH, linear regression analyses revealed generally similar results to those in glaucomatous eyes. In glaucomatous eyes without DH, mVD was significantly associated with age, MD, and GCIPL thickness in the univariate analyses and with MD in the multivariate analyses (β = 0.121, P = 0.004; Table 5).

Table 4 Subgroup characteristics between glaucomatous eyes with or without disc haemorrhage.
Table 5 Association between vessel density and demographic and ocular variables in glaucoma subgroups.

In glaucomatous eyes with DH, MAP was significantly associated with mVD in the univariate and multivariate analysis (β = −0.105, P = 0.003; β = −0.111, P = 0.003, respectively; Table 5). After adjusting for age, MD, and GCIPL thickness, the association between MAP and mVD was maintained in the multivariate analysis. Simple linear regression between MAP and mVD in glaucomatous eyes without and with DH is represented in Fig. 1. Figure 2 is a scatterplot between MAP and predicted mVD obtained from multivariate analysis adjusting compounding factors like age, MD and GCIPL thickness, so it can show the independent relationship between MAP and mVD. When compounding factors were adjusted, the inverse relationship between mVD and MAP became stronger in glaucoma group with DH.

Fig. 1: Plots of macular vessel density (mVD) versus mean arterial pressure (MAP) in glaucomatous eyes without disc haemorrhage (left) and in glaucomatous eyes with disc haemorrhage (right).
figure 1

In eyes with disc haemorrhage, mVD inversely correlates with MAP with signification. Solid line represents simple linear regression with 95% confidence interval marked with dash lines.

Fig. 2: Plots of predicted macular vessel density (mVD) versus mean arterial pressure (MAP) in glaucomatous eyes without disc haemorrhage (left) and in glaucomatous eyes with disc haemorrhage (right).
figure 2

Linear regression shows a more inverse relationship between predicted mVD and MAP in eyes with disc haemorrhage. Solid line represents simple linear regression with 95% confidence interval marked with dash lines.

Discussion

In the present study, we investigated the relationship between multiple clinical parameters and superficial mVD, detected using OCTA, in healthy eyes and glaucomatous eyes. The factors associated with mVD in healthy and glaucomatous eyes were mostly consistent with those reported in prior OCTA-based studies specified below. Here, age was associated with mVD in both healthy and glaucomatous eyes. In particular, age appeared to be an important factor associated with macular blood flow in the multivariate linear regression. In healthy eyes, most studies have shown that mVD decreases with increasing age [11, 13, 14, 24,25,26,27]. Only Gadde et al. [28] reported that age did not affect superficial capillary VD. A relatively small sample size (n = 18) may partially explain differences in these results. In glaucomatous eyes, Wu et al. [13] and Lommatzsch et al. [14] found a significant negative association between age and VD. Furthermore, Shoji et al. [11] reported that the rate of mVD decline accelerated with an increasing age.

We also found that in glaucomatous eyes, mVD was strongly associated with VF MD in the multivariate analysis. OCT structural parameters such as GCIPL and functional parameters such as VF MD values have also been found to correlate with mVD [12,13,14]. In all three studies, mVD had a slightly stronger association with the ganglion cell complex than VF parameters. These studies used AngioVue™ OCTA (RTVue-XR; Optovue, Inc., Fremont, CA, USA) and a different analysis method than that used here. These factors may have led to differences with the current study. Furthermore, decreased VD is significantly associated with functional loss severity, independent of structural loss [29, 30]. A recent study using AngioPlex™ OCTA further demonstrated that mVD was more robustly associated with functional measures of glaucoma than structural ones [31]. Therefore, future studies on the relationship between VD and OCT-structural and functional parameters are needed.

Subgroup analyses revealed that glaucomatous eyes without DH were similar to all eyes with glaucoma. In contrast, MAP was the only factor that was significantly associated with mVD in glaucomatous eyes with DH. After adjusting for age, GCIPL thickness, and VF MD, MAP retained a negative correlation with mVD.

Retinal circulation is autoregulated, meaning that within a certain range, flow is independent of perfusion pressure [32,33,34,35]. Furthermore, the autoregulation of blood supply to the ONH may be less efficient than that to the retina but more efficient than that to the choroid [36,37,38,39]. In glaucoma patients, this retinal and ONH vascular autoregulation may be disturbed, inhibiting the modulation of vascular parameters in response to fluctuations in ocular perfusion pressure [40,41,42,43,44]. Therefore, the idea that BP affects ocular perfusion is reasonable. Although mVD derived from OCTA is not a global indicator of retinal blood flow, it logically follows that changes in retinal blood flow may also lead to changes in mVD. Previous studies using OCTA found no significant correlation between BP and ONH VD in glaucoma patients [7, 45]. Shoji et al. [11] found that diastolic BP and mean ocular perfusion pressure were weakly and positively correlated with mVD (β = 0.02, P = 0.019; β = 0.08, P = 0.050), although this was not reproduced in the multivariate analyses. These previous results are similar to those reported here, in which MAP and mVD in all eyes with glaucoma were not correlated. Interestingly, in glaucomatous eyes with DH, there was an inverse correlation between MAP and mVD.

The underlying pathophysiological mechanisms of DH in glaucoma remain poorly understood. Currently, the two leading theories are a mechanical influence and a vascular mechanism [46]. Many previous studies have suggested a structural changes in lamina cribrosa as a cause of DH [47,48,49,50]. The common location of DH and the association between DH and glaucomatous structure damage support this mechanical mechanism. However, explaining DH is limited when there is no spatial correlation. It has long been suggested that microvascular ischaemia and autoregulatory dysfunction drive DH development. This theory proposes that vascular vulnerabilities lead to the damage of small vessels around the ONH, micro-occlusion of small retinal vessels, or shear stress-induced damage to vessel walls [46]. Several possible causative factors, including systemic vascular diseases, platelet dysfunction, primary vascular dysregulation, vasospasm, and dysfunctional autoregulation of optic nerve blood flow, have been suggested [51,52,53,54]. In addition, microinfarction and ischaemic changes may render capillaries more vulnerable to mechanical vessel rupture [55].

The theory that vascular mechanisms underlie DH development is inconclusive, but it is reasonable to assume that these may play an adjunctive role. Therefore, patients with DH might also exhibit reduced VD because hypertension is known to cause microvasculature damage. A reduced number of arterioles and capillaries has been known as microvascular rarefaction. An inverse correlation between capillary densities and BP has been identified in animal studies [56, 57]. In addition, human dermal and muscle tissue showed microvascular rarefaction in patients with primary hypertension [58,59,60,61].

Bosch et al. [62] reported that patients with untreated hypertension exhibited more retinal capillary rarefaction than healthy subjects. One noteworthy finding in the present study was that the absolute BP magnitude was related to mVD rather than simply to a hypertension diagnosis. This indicates that the degree of BP control is more important than a diagnosis of hypertension and that well-controlled hypertension may delay the progression of retinal microvasculature damage in glaucoma group with DH.

One limitation of the present study is the use of a single systemic BP measurement as BP is known to fluctuate over time [56]. Measurements at different times of the day [57] or year [58], in different arms [59], or with different cuff sizes [60] can affect the measured values, thereby introducing variability. In addition, as BP was measured at the hospital for this study, the possibility of white coat hypertension cannot be ignored. BPs of all patient were measured using the same automated BP monitor located in the ophthalmology department so that it could minimize this variability. In addition, to ensure accurate BP readings at OCTA scanning, we evaluated the time between OCTA and BP measurements and it did not exceed the maximum of 4 h. This was possible because routine glaucoma screening or follow-up included BP measurement of every patient. Patients were guided to measure BP after 20 min of inactivity during the waiting time.

Another limitation of the present study was that some glaucoma participants used topical antiglaucoma drugs. There is some evidence that topical antiglaucoma drugs can change blood flow in the ONH [61, 63]. Takusagawa et al. [12] found an association between topical β-blocker use and decreased macular VD in glaucomatous eyes measured using OCTA. We did not have participants discontinue antiglaucoma medication use before study commencement for ethical and medical reasons, excluding cases in which the IOP was well controlled after glaucoma surgery or where short-term follow-up observation was performed. In addition, given that systemic antihypertensive drug use and antihypertensive treatment duration had not been evaluated, any potentially confounding effect of these drugs on mVD could not be totally excluded here. In addition, poor evaluation of maximal untreated IOP might have an impact on the selection bias of subgroup analysis.

In conclusion, the present study demonstrates that age affects mVD, as measured using OCTA, in both healthy and glaucomatous eyes. Furthermore, mVD and functional and structural changes are correlated in glaucomatous eyes. However, in glaucomatous eyes with DH, high systemic BP was associated with reduced mVD. This indicates that retinal vessels may be more susceptible to damage induced by high BP in glaucomatous eyes with DH. The present study, which uses OCTA, highlights novel non-IOP mechanisms for determining the health of glaucomatous eyes with DH.

Summary

What was known before

  • Using optical coherence tomography angiography (OCTA), reduced microvascularity of retinal layer has been revealed in glaucoma patients.

  • Macular vessel density(mVD) can be a important index for glaucomatous change because of its anatomical and pathological meaning.

What this study adds

  • Older age is associated with reduced macular vessel density (mVD) in both healthy and glaucomatous eyes

  • Reduced mVD also correlates with functional deterioration than structure damage in glaucomatous eyes.

  • In glaucomatous eyes with disc haemorrhage, high systemic BP is associated with a reduction in mVD.